Related Experiment Video
Updated: Feb 15, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Heart failure in grown-up congenital heart disease
Alessia Faccini1, Angelo Micheletti1, Diana G Negura1
1Pediatric and Adult Congenital Heart Center, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.
Insights
Adults with congenital heart disease (ACHD) face increased heart failure (HF) hospitalizations and mortality. Early identification and dedicated monitoring are crucial for managing HF in this growing population.
Area of Science:
- Cardiology
- Adult Congenital Heart Disease (ACHD)
Background:
- Increasing survival rates in congenital heart disease (CHD) have shifted focus to adult populations (ACHD).
- Adult congenital heart disease patients experience rising hospitalization rates due to heart failure (HF).
- ACHD patients with HF face a five-fold higher mortality risk compared to compensated patients.
Purpose of the Study:
- To highlight the unique challenges in diagnosing and managing heart failure (HF) in adult congenital heart disease (ACHD) patients.
- To emphasize the need for specialized monitoring and management strategies for HF in ACHD.
Main Methods:
- Review of current diagnostic and therapeutic strategies for HF in ACHD.
- Analysis of HF prevalence in specific ACHD conditions like tetralogy of Fallot, single ventricles, and post-Mustard operation.
Main Results:
- Heart failure predominantly affects ACHD patients with specific conditions, including tetralogy of Fallot, single ventricles, and those post-Mustard operation.
- Standard diagnostic and therapeutic approaches for acquired HF may not be fully adequate or timely for ACHD patients.
- Unusual signs and symptoms can delay HF identification in ACHD.
Conclusions:
- Dedicated monitoring units are essential for timely HF identification and management in ACHD.
- Current therapeutic management for HF in ACHD mirrors acquired HF, despite a lack of specific large randomized trials.
- Proactive and specialized care is imperative for improving outcomes in ACHD patients with heart failure.
Abstract:
The increasing survival to adulthood of patients with congenital heart disease (CHD) has changed the epidemiology of adult CHD (ACHD) patients and has led to an increment in hospitalization rates due to heart failure (HF). ACHD patients hospitalized for HF have a five-fold higher risk of death than those compensated. HF occurs predominantly in patients with tetralogy of Fallot, single ventricles, and after the Mustard operation for transposition of the great arteries. Diagnostic strategies applied in acquired HF patients are usually used to evaluate ACHD patients, but sometimes this can postpone the identification of HF that can become manifest with unusual and peculiar signs or symptoms. In the same way, therapeutic management resembles the acquired HF one, even if no large randomized clinical trials have been conducted in ACHD patients. Therefore, a close monitoring in dedicated units is mandatory in order to identify in time HF manifestations and manage them adequately.
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure VI: Adjunct Therapies
Heart Failure Drugs: Diuretics
Heart Failure V: Medical Management

